Comparison of cholinesterase inhibitor safety in real‐world practice

Abstract Introduction Cholinesterase inhibitors (ChEIs) are widely used to treat mild to moderate Alzheimer's disease and related dementia. Clinical trials have focused on placebo comparisons, inadequately addressing within‐class comparative safety. Methods New users of ChEIs in British Columbi...

Full description

Saved in:
Bibliographic Details
Main Authors: Greg Carney, Ken Bassett, James M. Wright, Malcolm Maclure, Nicolette McGuire, Colin R. Dormuth
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Online Access:https://doi.org/10.1016/j.trci.2019.09.011
Tags: Add Tag
No Tags, Be the first to tag this record!